atcc deposit no 209037 (ATCC)
ATCC is a verified supplier 
ATCC manufactures this product 
90
Structured Review
ATCC
atcc deposit no 209037
Atcc Deposit No 209037, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 22 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/atcc+deposit+no+209037/DNA+Plasmid+2149226/us07776560-95-30-30
Average 90 stars, based on 22 article reviews
Atcc Deposit No 209037, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 22 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/atcc+deposit+no+209037/DNA+Plasmid+2149226/us07776560-95-30-30
Average 90 stars, based on 22 article reviews
atcc deposit no 209037 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Isolation:Article Title: Human tumor necrosis factor receptor TR9 antibody Article Snippet: .. In another aspect, the invention provides isolated nucleic acid molecules encoding the TR9 receptor polypeptide having an amino acid sequence as encoded by the cDNA clone contained in the plasmid deposited as Article Title: Human tumor necrosis factor receptor TR9 Article Snippet: .. In another aspect, the invention provides isolated nucleic acid molecules encoding the TR9 receptor polypeptide having an amino acid sequence as encoded by the cDNA clone contained in the plasmid deposited as Sequencing:Article Title: Human tumor necrosis factor receptor TR9 antibody Article Snippet: .. In another aspect, the invention provides isolated nucleic acid molecules encoding the TR9 receptor polypeptide having an amino acid sequence as encoded by the cDNA clone contained in the plasmid deposited as Article Title: Human tumor necrosis factor receptor TR9 Article Snippet: .. In another aspect, the invention provides isolated nucleic acid molecules encoding the TR9 receptor polypeptide having an amino acid sequence as encoded by the cDNA clone contained in the plasmid deposited as Article Title: Human tumor necrosis factor receptor TR9 antibody Article Snippet: .. The present invention encompasses polypeptides comprising, or alternatively consisting of, an epitope of the polypeptide having an amino acid sequence of SEQ ID NO:2, or an epitope of the polypeptide sequence encoded by a polynucleotide sequence contained in Article Title: Human tumor necrosis factor receptor TR9 antibody Article Snippet: .. Therefore, the present invention provides a nucleotide sequence encoding the mature TR9 receptor polypeptides having the amino acid sequence encoded by the cDNA clone contained in the host identified as Article Title: Human tumor necrosis factor receptor TR9 antibody Article Snippet: By the mature TR9 protein having the amino acid sequence encoded by the cDNA clone contained in the host identified as ATCC Deposit 209037 is meant the mature form(s) of the TR9 receptor produced by expression in a mammalian cell (e.g., COS cells, as described below) of the complete open reading frame encoded by the human DNA sequence of the clone contained in the vector in the deposited host. .. As indicated below, the mature TR9 receptor having the amino acid sequence encoded by the cDNA clone contained in Article Title: Human tumor necrosis factor receptor TR9 Article Snippet: .. Therefore, the present invention provides a nucleotide sequence encoding the mature TR9 receptor polypeptides having the amino acid sequence encoded by the cDNA clone contained in the host identified as Plasmid Preparation:Article Title: Human tumor necrosis factor receptor TR9 antibody Article Snippet: .. In another aspect, the invention provides isolated nucleic acid molecules encoding the TR9 receptor polypeptide having an amino acid sequence as encoded by the cDNA clone contained in the plasmid deposited as Article Title: Human tumor necrosis factor receptor TR9 Article Snippet: .. In another aspect, the invention provides isolated nucleic acid molecules encoding the TR9 receptor polypeptide having an amino acid sequence as encoded by the cDNA clone contained in the plasmid deposited as other:Article Title: Human tumor necrosis factor receptor TR9 Article Snippet: Further embodiments of the invention include isolated nucleic acid molecules comprising a polynucleotide having a nucleotide sequence at least 90% identical, and more preferably at least 95%, 96%, 97%, 98% or 99% identical to (a) a nucleotide sequence encoding the polypeptide having the amino acid sequence shown in FIGS. 1A-D (SEQ ID NO:2); (b) a nucleotide sequence encoding the polypeptide having the amino acid sequence shown in FIGS. 1A-D (SEQ ID NO:2), but lacking the N-terminal methionine; (c) a nucleotide sequence encoding the predicted mature TR9 polypeptide (full-length polypeptide with any attending leader sequence removed) comprising the amino acid sequence at positions from about 1 to about 615 in SEQ ID NO:2; (d) a nucleotide sequence encoding the TR9 polypeptide having the amino acid sequence encoded by the cDNA clone contained in Article Title: Human tumor necrosis factor receptor TR9 antibody Article Snippet: Further embodiments of the invention include isolated nucleic acid molecules comprising, or alternatively consisting of, a polynucleotide having a nucleotide sequence at least 90% identical, and more preferably at least 80%, 85%, 95%, 96%, 97%, 98% or 99% identical to (a) a nucleotide sequence encoding the polypeptide having the amino acid sequence shown in FIGS. 1A-D (SEQ ID NO:2); (b) a nucleotide sequence encoding the polypeptide having the amino acid sequence shown in FIGS. 1A-D (SEQ ID NO:2), but lacking the N-terminal methionine; (c) a nucleotide sequence encoding the predicted mature TR9 polypeptide (full-length polypeptide with any attending leader sequence removed) comprising, or alternatively consisting of, the amino acid sequence at positions from about 1 to about 615 in SEQ ID NO:2; (d) a nucleotide sequence encoding the TR9 polypeptide having the amino acid sequence encoded by the cDNA clone contained in Hybridization:Article Title: Human tumor necrosis factor receptor TR9 antibody Article Snippet: .. The present invention encompasses polypeptides comprising, or alternatively consisting of, an epitope of the polypeptide having an amino acid sequence of SEQ ID NO:2, or an epitope of the polypeptide sequence encoded by a polynucleotide sequence contained in |